Effects of Different Temperature and Time Durations of Virus Inactivation on Results of Real-time Fluorescence PCR Testing of COVID-19 Viruses

Abstract

The novel Coronavirus SARS-CoV-2 caused an outbreak of pneumonia in Wuhan, Hubei province of China in January 2020. This study aims to investigate the effects of different temperature and time durations of virus inactivation on the results of PCR testing for SARS-CoV-2. Twelve patients at the Renmin Hospital of Wuhan University suspected of being infected with SARS-CoV-2 were selected on February 13, 2020 and throat swabs were taken. The swabs were stored at room temperature (20–25°C), then divided into aliquots and subjected to different temperature for different periods in order to inactivate the viruses (56°C for 30, 45, 60 min; 65, 70, 80°C for 10, 15, 20 min). Control aliquots were stored at room temperature for 60 min. Then all aliquots were tested in a real-time fluorescence PCR using primers against SARS-CoV-2. Regardless of inactivation temperature and time, 7 of 12 cases (58.3%) tested were positive for SARS-CoV-2 by PCR, and cycle threshold values were similar. These results suggest that virus inactivation parameters exert minimal influence on PCR test results. Inactivation at 65°C for 10 min may be sufficient to ensure safe, reliable testing.

Keywords

SARS-CoV-2 / COVID-19 / throat swabs / real-time fluorescence PCR

References

[1] LIN YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res, 2020,7(1):.

[2] SheJ, JiangJ, YeL, et al.. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med, 2020, 9(1): 19

[3] RyuS, ChunBC. Korean Society of Epidemiology 2019-nCoV Task Force Team. An interim review of the epidemiological characteristics of 2019 novel coronavirus. Epidemiol Health, 2020, 42: e2020006

[4] HolshueML, DeBoltC, LindquistS, et al.. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med, 2020, 382(10): 929-936

[5] Chinese National Health Committee. The latest epidemic situation of the new coronavirus pneumonia at 24:00 on Apirl 10 (Chinese). http://www.nhc.gov.cn/xcs/yqtb/202004/be5fdf84937844bcb88841c2c6bb8145.shtml.

[6] CormanVM, LandtO, KaiserM, et al.. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill, 2020, 25(3): 1-8

[7] General Office of the Chinese National Health Commission. New coronavirus pneumonia diagnosis and treatment, a clinical guideline and database (trial version 6) (Chinese), 2020, 02(01): e2-e2

[8] MahaseE. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ, 2020, 368: m641

[9] BinnickerMJ. Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak. Clin Chem, 2020, 66(5): 664-666

[10] KariwaH, FujiiAN, TakashimaBI. Inactivation of SARS Coronavirus by Means of Povidone-Iodine, Physical Conditions and Chemical Reagents. Dermatology, 2006, 212(Suppl 1): 119-123